Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations

JOURNAL OF INVESTIGATIVE DERMATOLOGY

ELSEVIER SCIENCE INC

1. Programme Hospitalier de Recherche Clinique Region SUD